TRANSPORT2 is a clinical trial for patients who have suffered their first ever ischemic stroke with in the last 6 months, resulting in arm weakness.
Research Eligibility:
Ages 18-80
Had a stroke less than 6 months ago
Have arm weakness
Do not have any implanted medical devices
Study Goal:
TRANSPORT2 is a federally funded, randomized, blinded clinical trial in search of a way to provide effective treatment for arm weakness in patients who have suffered an ischemic stroke.
Study Summary:
This research is being done to find out if brain stimulation combined with an established noninvasive rehabilitation therapy improves arm weakness. The stimulation technique being used is called transcranial direct current stimulation (tDCS). The treatment uses weak electrical currents to stimulate specific parts of the brain. The rehabilitation therapy is called “modified Constraint Induced Movement Therapy” (mCIMT). During this therapy you will wear a mitt on your hand that was not affected by the stroke. It is designed to restrain the use of your good hand, while performing therapy with your impaired arm.
Principal Investigator:
George Wittenberg, MD, PhD
Study Coordinator:
Jason Weimer
412 -647 -5615